allergic rhinitis. Allergic rhinitis due to pollen
Conditions
Interventions
Intervention 1: Intervention group: The treatment group received a 300 mg capsule containing Avena sativa extract twice daily for 14 days. Intervention 2: Control group: The control group received 300
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: People aged 18 to 65 years With a diagnosis of allergic rhinitis
Exclusion criteria
Exclusion criteria: Pregnancy Nasal polyps Corticosteroid use in the past 4 weeks Antihistamine use in the past one week Having underlying medical conditions especially autoimmune and celiac diseases Allergy to 2nd generation antihistamines and oats
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of eosinophils in nasal smears. Timepoint: Before beginning the treatment and at the end of the second week of treatment. Method of measurement: Counting the number of eosinophils in nasal smears.;Symptoms of allergic rhinitis. Timepoint: Before beginning the treatment and at the end of the second week of treatment. Method of measurement: Recording symptoms of allergic rhinitis by asking the patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Dabaghzadeh
Kerman University of Medical Sciences
Outcome results
None listed